COVID-19 Response: Local Logistics     National Effort       

Drug Discovery Services

You are here

COVID-19 Response: Local Logistics     National Effort

Antimicrobial Drug Development Studies

in collaboration with

C-CAMP in collaboration with IHMA, a premier provider of antimicrobial drug development studies, offers a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development: drug discovery, clinical development, regulatory approval and commercialization. With facilities in the USA, Europe, China and India, IHMA is able to collaborate with and support companies around the world in the pharmaceutical, biotechnology and diagnostic device industry.

We partner with companies requiring:

  • Pre-clinical studies including in vitro studies (antibacterial and antifungal)
    • MIC Profiling
    • Time Kill
    • Resistance Development
    • Drug Interactions
    • Post-antibiotic Effect
  • Global support of all phases of clinical trials
    • Therapeutics
    • Diagnostic Devices
  • Antimicrobial resistance (AMR) surveillance
    • Bacterial
    • Fungal
  • Molecular Characterization of AMR
    • WGS Diagnostics
  • Support with New Therapeutic Approaches
    • Bacteriophage

More details on IHMA at

To request a service, contact services[at]